Kimberly-Clark Corp. engages in the manufacture and marketing of products made from natural or synthetic fibers. It operates through the following segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, training and youth pants, swim pants, baby wipes, feminine and incontinence care products, and other related products. The Consumer Tissue segment produces and sells facial and bathroom tissue, paper towels, napkins, and related products for household use. The K-C Professional segment supplies workplace supporting products such as wipers, tissue, towels, apparel, soaps, and sanitizers. The company was founded by John A. Kimberly, Havilah Babcock, Charles B. Clark, and Frank C. Shattuck in 1872 and is headquartered in Irving, TX.

Probiotical SpA manufactures probiotic lactic ferments. It offers probiotics, healthcare, food supplements, LBPs, pharma, synbiotics, medical devices, and clinical studies. The company was founded in 1985 and is headquartered in Novara, Italy.

PhagoMed is a developer of a biotech platform designed to develop drugs and therapies.The company's platform is focused on the development of human therapeutic applications of phages and phage-derived proteins associated with urinary tract infections and bacterial vaginosis, enabling patients to get antibiotics.

Unibio Corp. operates as a laboratory to generate protein substances. The company was founded by Yoji Yuki on March 11, 2011 and is headquartered in Niigata, Japan

Melinta Therapeutics is an antibiotics-focused company. The company’s mission is to discover, develop and commercialize urgently needed, groundbreaking antibiotics to overcome drug-resistant, life-threatening infections. The need for new therapies for drug-resistant infections is widely recognized as one of the most serious public health issues facing the world today. To meet this need, Melinta Therapeutics is rapidly progressing its late-stage investigational antibiotic, delafloxacin, which is currently in Phase 3 development for acute bacterial skin and skin structure infections (ABSSSI). In addition, Melinta is focused on its ongoing research program to develop a new class of antibiotics designed to overcome the resistant ESKAPE pathogens known to cause the majority of serious hospital infections and patient deaths. Melinta Therapeutics is privately held and backed by Vatera Healthcare Partners and Warburg Pincus.

VESALE Pharmaceutica is a private company headquartered in Noville-sur-Mehaigne, Belgium, with domestic subsidiaries. The firm manufactures macrobiotics and cosmetics. It was founded in 1994. Jehan Lienart van Lidth de Jeude is currently the CEO of the company.

KoBioLabs, Inc. engages in the research and development of the microbiome. Its product is involved in the industries such as therapeutics, diagnostics, cosmetics, agriculture, and veterinary medicine. The company was founded by Ko Gwang-Pyo on August 11, 2014 and is headquartered in Seoul, South Korea.

Jiangsu Runjie Biotechnology Co., Ltd., established on 2016-07-15, Business scope includes biomedical technology research and development,Technical Services,technology transfer;anti-(suppress)Bacterial preparation(suppositories,except soap)(gel,liquid,ointment)(purify),sanitary napkin,Production and sales of sanitary wipes;Biological product,medicine,one type,Class II,Three types of medical device research and development,Production,Sales;Healthy food,cosmetic,Sales of cleaning products;Conference Consulting,Enterprise Marketing Planning;Acquisition of agricultural and sideline products,First Processing,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

CC Biotech Ltd. is a company headquartered in Cambridge, UK. The firm develops proprietary drug discovery platform. It was founded by Matthew Cummings and David Corcoran. Matthew Cummings has been the CEO since 2018.

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

MEDIOGEN is a life science and probiotics products company.

Beijing Scitop Bio-tech Co., Ltd. engages in the research and development, production, and sale of compound food additives. It also offers edible probiotic products, and animal and plant probiotic products. The company was founded on September 5, 2003 and is headquartered in Beijing, China.

AimMax Therapeutics, Inc. researches and develops pharmaceuticals and therapeutics. The company was founded in 2016 and is headquartered in Chapel Hill, NC.

Jinhua Galaxy Biotechnology Co., Ltd., established on 2003-06-03, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;food sales(Only sell prepackaged food);Food Additive Sales;fertilizer sales;Feed Additive Sales;General merchandise sales;Cosmetics Retail;Sales of hygiene products and single-use medical products;Personal Hygiene Sales;Import and export;Technology Import and Export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:food production;beverage production;Food additive production;fertilizer production;Feed additive production(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).

Freya Biosciences ApS is a company headquartered in Copenhagen, Denmark, that develops microbial immunotherapies for reproductive health. The firm was founded by Ulrich Binné, Colleen Acosta, Johan van Hylckama Vlieg and Randi Rich. Colleen Acosta is the current CEO of the company.\nThe company says this about itself: Freya is a biotech company based in Copenhagen, Denmark, dedicated to advancing women's reproductive health. With a focus on reproductive microbial immunotherapy interventions, Freya aims to improve fertility outcomes and empower women with innovative solutions.